Vinati Organics Ltd
Incorporated in 1989, Vinati Organics Ltd manufactures specialty organic intermediaries
and Monomers[1]
- Market Cap ₹ 18,660 Cr.
- Current Price ₹ 1,800
- High / Low ₹ 2,331 / 1,412
- Stock P/E 44.9
- Book Value ₹ 271
- Dividend Yield 0.38 %
- ROCE 20.6 %
- ROE 15.8 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.4%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE 500 BSE SmallCap BSE Allcap BSE Commodities BSE 250 SmallCap Index
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
696 | 772 | 631 | 641 | 730 | 1,128 | 1,029 | 954 | 1,616 | 2,066 | 1,900 | 2,248 | |
543 | 580 | 424 | 423 | 531 | 703 | 614 | 601 | 1,180 | 1,493 | 1,429 | 1,663 | |
Operating Profit | 153 | 192 | 207 | 218 | 198 | 425 | 415 | 353 | 435 | 573 | 471 | 585 |
OPM % | 22% | 25% | 33% | 34% | 27% | 38% | 40% | 37% | 27% | 28% | 25% | 26% |
9 | 9 | 6 | 12 | 31 | 30 | 45 | 26 | 61 | 52 | 39 | 44 | |
Interest | 18 | 10 | 8 | 3 | 2 | 2 | 2 | 1 | 2 | 3 | 5 | 1 |
Depreciation | 15 | 18 | 19 | 22 | 23 | 27 | 33 | 43 | 45 | 59 | 73 | 81 |
Profit before tax | 129 | 174 | 187 | 206 | 203 | 425 | 425 | 335 | 449 | 563 | 432 | 548 |
Tax % | 33% | 33% | 29% | 32% | 29% | 34% | 21% | 20% | 23% | 26% | 25% | 24% |
86 | 116 | 132 | 140 | 144 | 282 | 334 | 269 | 347 | 419 | 323 | 415 | |
EPS in Rs | 8.75 | 11.22 | 12.75 | 13.59 | 14.00 | 27.48 | 32.48 | 26.20 | 33.73 | 40.78 | 31.20 | 40.05 |
Dividend Payout % | 17% | 16% | 16% | 2% | 16% | 13% | 17% | 23% | 19% | 17% | 22% | 19% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 17% |
3 Years: | 12% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | 4% |
3 Years: | 6% |
TTM: | 28% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | 14% |
3 Years: | -5% |
1 Year: | 7% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 18% |
3 Years: | 17% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 300 | 424 | 530 | 670 | 786 | 1,041 | 1,269 | 1,533 | 1,851 | 2,203 | 2,454 | 2,796 |
162 | 65 | 42 | 2 | 15 | 4 | 0 | 2 | 28 | 35 | 5 | 63 | |
80 | 100 | 104 | 139 | 168 | 173 | 163 | 188 | 260 | 335 | 358 | 394 | |
Total Liabilities | 552 | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 |
304 | 327 | 382 | 468 | 457 | 475 | 751 | 757 | 874 | 1,159 | 1,330 | 1,382 | |
CWIP | 10 | 20 | 25 | 7 | 35 | 191 | 31 | 55 | 306 | 229 | 246 | 298 |
Investments | 3 | 3 | 3 | 62 | 132 | 96 | 227 | 289 | 98 | 256 | 237 | 523 |
235 | 249 | 278 | 284 | 356 | 465 | 434 | 633 | 872 | 940 | 1,014 | 1,059 | |
Total Assets | 552 | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
131 | 113 | 167 | 130 | 138 | 200 | 416 | 219 | 127 | 516 | 338 | 494 | |
-9 | -53 | -72 | -27 | -39 | -243 | -197 | -198 | -256 | -333 | -353 | -480 | |
-113 | -75 | -50 | -45 | -30 | -40 | -109 | -3 | -46 | -61 | -106 | -15 | |
Net Cash Flow | 9 | -16 | 45 | 59 | 70 | -83 | 109 | 18 | -175 | 121 | -122 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 60 | 61 | 66 | 80 | 89 | 79 | 72 | 106 | 102 | 82 | 102 | 96 |
Inventory Days | 41 | 44 | 55 | 79 | 79 | 64 | 79 | 115 | 85 | 79 | 72 | 66 |
Days Payable | 12 | 17 | 28 | 40 | 61 | 37 | 47 | 62 | 52 | 41 | 36 | 43 |
Cash Conversion Cycle | 89 | 87 | 94 | 119 | 107 | 106 | 104 | 158 | 136 | 120 | 137 | 119 |
Working Capital Days | 52 | 58 | 62 | 119 | 121 | 112 | 97 | 138 | 148 | 113 | 140 | 119 |
ROCE % | 30% | 38% | 36% | 33% | 28% | 46% | 37% | 24% | 26% | 27% | 19% | 21% |
Documents
Announcements
- Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015, Regarding Additional Investment In Veeral Organics Pvt. Ltd., Wholly Owned Subsidiary Company. 2m
-
Announcement Under Regulation 30 (LODR)-Earnings Call Transcript
1d - Vinati Organics Q4 FY25: 18% revenue growth, INR400 Cr capex, ATBS capacity expansion, strong 3-year 20% CAGR outlook.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
1d - Vinati Organics' Annual Secretarial Compliance Report confirms full regulatory compliance for FY ended March 31, 2025.
-
Interview Of Ms. Vinati Saraf Mutreja, MD & CEO With CNBC - TV18
1d - CEO interview on Q4 and FY25 financial performance aired on CNBC-TV18.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16 May - Audio recording link of Q4 and FY2025 investors' conference call released.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
Concalls
-
May 2025TranscriptPPTREC
-
Aug 2024TranscriptPPT
-
Aug 2024TranscriptPPT
-
May 2024TranscriptPPTREC
-
Feb 2024TranscriptPPTREC
-
Aug 2023TranscriptPPT
-
Feb 2021TranscriptPPT
-
Aug 2018TranscriptPPT
Product Offerings
The company’s product portfolio includes over 30 products across: [1]